Furthermore, ALDH1A1 has been associated with glioblastoma proliferation and migration (17, 18), while decreased ALDH1A1 expression could restore GBM cell sensitivity to temozolomide, a common and efficient chemotherapeutic drug for GBM (19). The gene discussed is ALDH1A1; the disease is glioblastoma.